Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
Open Access
- 1 July 1999
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (1) , 13-19
- https://doi.org/10.1172/jci5628
Abstract
The Fas ligand is predominantly expressed in activated T lymphocytes and is one of the major effector molecules of cytotoxic T lymphocytes and natural killer cells. Previously, we found excessive apoptosis of epithelial cells and infiltrating lymphocytes expressing Fas ligand mRNA in the lung tissue of bleomycin-induced pulmonary fibrosis in mice. Here we demonstrated that the administration of a soluble form of Fas antigen or anti-Fas ligand antibody prevented the development of this model and that lpr and gld mice were resistant against the induction of pneumopathy. These results suggest that the Fas-Fas ligand pathway plays an essential role in the development of pulmonary fibrosis and that preventing this pathway could have therapeutic value in lung injury and fibrosis.Keywords
This publication has 38 references indexed in Scilit:
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Sensitivity of Insulin-Secreting RIN m5F Cells to Undergoing Apoptosis by the Protein Kinase C Inhibitor StaurosporineExperimental Cell Research, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Interstitial Lung Diseases of Unknown CauseNew England Journal of Medicine, 1984